304 related articles for article (PubMed ID: 27584025)
1. Cancer immunotherapy: new applications in urologic oncology.
Hurwitz ME; Sokhn J; Petrylak DP
Curr Opin Urol; 2016 Nov; 26(6):535-42. PubMed ID: 27584025
[TBL] [Abstract][Full Text] [Related]
2. Cancer immunotherapy: new applications in urologic oncology.
Mullane SA; Bellmunt J
Curr Opin Urol; 2016 Nov; 26(6):556-63. PubMed ID: 27584023
[TBL] [Abstract][Full Text] [Related]
3. Current and Future Applications of Novel Immunotherapies in Urological Oncology: A Critical Review of the Literature.
Özdemir BC; Siefker-Radtke AO; Campbell MT; Subudhi SK
Eur Urol Focus; 2018 Apr; 4(3):442-454. PubMed ID: 29056275
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in immuno-oncology and its application to urological cancers.
Mataraza JM; Gotwals P
BJU Int; 2016 Oct; 118(4):506-14. PubMed ID: 27123757
[TBL] [Abstract][Full Text] [Related]
5. The Role of Immunotherapy in Urologic Cancers.
May A; Roustio L; Hamilton ZA
Mo Med; 2020; 117(2):127-132. PubMed ID: 32308237
[TBL] [Abstract][Full Text] [Related]
6. The role of immunotherapy for urological tumours.
Hrouda D; Muir GH; Dalgleish AG
Br J Urol; 1997 Mar; 79(3):307-16. PubMed ID: 9117206
[No Abstract] [Full Text] [Related]
7. Prime time for immunotherapy in advanced urothelial cancer.
Jiang DM; Sridhar SS
Asia Pac J Clin Oncol; 2018 Nov; 14 Suppl 5():24-32. PubMed ID: 30489031
[TBL] [Abstract][Full Text] [Related]
8. Novel immunotherapy combinations for genitourinary cancers.
Al Harthy M; Redman J; Madan RA
Expert Opin Biol Ther; 2020 Mar; 20(3):253-262. PubMed ID: 31914333
[TBL] [Abstract][Full Text] [Related]
9. Recent progress in immunotherapy for urological cancer.
Obara W; Kato R; Kato Y; Kanehira M; Takata R
Int J Urol; 2017 Oct; 24(10):735-742. PubMed ID: 28636222
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy in kidney cancer: the past, present, and future.
Hammers H
Curr Opin Urol; 2016 Nov; 26(6):543-7. PubMed ID: 27533501
[TBL] [Abstract][Full Text] [Related]
11. Cancer immunotherapy: A paradigm shift in the treatment of advanced urologic cancers.
Gill DM; Agarwal N
Urol Oncol; 2017 Dec; 35(12):676-677. PubMed ID: 29054496
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the use of therapeutic cancer vaccines in genitourinary malignancies.
Surolia I; Gulley J; Madan RA
Expert Opin Biol Ther; 2014 Dec; 14(12):1769-81. PubMed ID: 25212872
[TBL] [Abstract][Full Text] [Related]
13. Novel therapeutic targets in advanced urothelial carcinoma.
Rouanne M; Loriot Y; Lebret T; Soria JC
Crit Rev Oncol Hematol; 2016 Feb; 98():106-15. PubMed ID: 26589398
[TBL] [Abstract][Full Text] [Related]
14. A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G.
Carosella ED; Ploussard G; LeMaoult J; Desgrandchamps F
Eur Urol; 2015 Aug; 68(2):267-79. PubMed ID: 25824720
[TBL] [Abstract][Full Text] [Related]
15. Rationing in urologic oncology: lessons from sipuleucel-T for advanced prostate cancer.
Peppercorn J; Armstrong A; Zaas DW; George D
Urol Oncol; 2013 Oct; 31(7):1079-84. PubMed ID: 22305627
[TBL] [Abstract][Full Text] [Related]
16. Personalized peptide vaccines and their relation to other therapies in urological cancer.
Kimura T; Egawa S; Uemura H
Nat Rev Urol; 2017 Aug; 14(8):501-510. PubMed ID: 28561807
[TBL] [Abstract][Full Text] [Related]
17. Vaccines in urologic malignancies.
Siemens DR; Ratliff TL
Urol Res; 2001 Jun; 29(3):152-62. PubMed ID: 11482438
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy with radiotherapy in urological malignancies.
Mehta S; Illidge T; Choudhury A
Curr Opin Urol; 2016 Nov; 26(6):514-22. PubMed ID: 27552139
[TBL] [Abstract][Full Text] [Related]
19. Novel therapies for advanced urologic cancers.
Heidenreich A
Curr Opin Urol; 2020 Jul; 30(4):594-601. PubMed ID: 32453002
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy for renal cell cancer.
Yang JC; Childs R
J Clin Oncol; 2006 Dec; 24(35):5576-83. PubMed ID: 17158543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
